Koers Ambu A/S Nasdaq Copenhagen
Aandelen
DK0060591204
Medische apparatuur, benodigdheden & distributie
Omzet 2024 * | 5,36 mld. 781 mln. 717 mln. | Omzet 2025 * | 6,04 mld. 881 mln. 809 mln. | Marktkapitalisatie | 36,42 mld. 5,31 mld. 4,88 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | 455 mln. 66,34 mln. 60,92 mln. | Nettowinst (verlies) 2025 * | 635 mln. 92,58 mln. 85,03 mln. | EV/omzet 2024 * | 6,83 x |
Nettoschuld 2024 * | 193 mln. 28,09 mln. 25,8 mln. | Nettoliquiditeiten 2025 * | 273 mln. 39,78 mln. 36,54 mln. | EV/omzet 2025 * | 5,98 x |
K/w-verhouding 2024 * |
71
x | K/w-verhouding 2025 * |
50,9
x | Werknemers | - |
Dividendrendement 2024 * |
0,21% | Dividendrendement 2025 * |
0,3% | Vrij verhandelbaar | 64,63% |
Recentste transcriptie over Ambu A/S
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 51 | 17-12-19 | |
Director of Finance/CFO | 40 | 01/01 | |
Finn Möhring
CTO | Chief Tech/Sci/R&D Officer | - | 01-08-23 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Jørgen Jensen
CHM | Chairman | 56 | 09-12-20 |
Christian Sagild
BRD | Director/Board Member | 64 | 01-01-12 |
Director/Board Member | 54 | 01-01-15 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
-5,21% | 181 mld. | |
+2,45% | 112 mld. | |
-2,88% | 67,92 mld. | |
+4,67% | 50,1 mld. | |
+7,89% | 44,27 mld. | |
+9,39% | 40,41 mld. | |
+25,43% | 31,95 mld. | |
-0,25% | 25,82 mld. | |
+17,27% | 25,29 mld. |